Please login to the form below

Not currently logged in
Email:
Password:
PMLiVE Top Pharma List

13

Revenue 2017

Bristol-Myers Squibb

The Top Pharma List rankings are compiled from GlobalData's pharmaceutical revenue figures, which are based on prescription medicine sales, including generics drugs. They have been compiled below into an infographic of Bristol-Myers Squibb's 2013 sales performance.

Bristol-Myers Squibb

Opdivo trial overshadows BMS financial results

Opdivo trial overshadows BMS financial results Hope remains in Celgene merger. Bristol-Myers Squibb posted a 10% increase in revenues in the second quarter, but reporting focused on mixed results in a trial of its main growth

PhRMA opposed to Senate drug price control plans

PhRMA opposed to Senate drug price control plans Speaking on Bristol-Myers Squibb’s results call yesterday, chief executive Giovanni Caforio said that while the situation in the US is “fluid”, there are worrying signs that the Senate approach

Otezla scores new indication as speculation over potential buyers grows

Otezla scores new indication as speculation over potential buyers grows The approval, announced on Friday, coincides with speculation around who will acquire the blockbuster treatment, which Bristol-Myers Squibb and Celgene have been told to sell off by the US authorities

FDA verdict on Sanofi’s Darzalex rival is due in April 2020

FDA verdict on Sanofi’s Darzalex rival is due in April 2020 Additional competition is however looming from MorphoSys and Takeda, which each have anti-CD38 drugs in pivotal-stage testing for myeloma, while another rival is Bristol-Myers Squibb and AbbVie’s

Citryll snares €15m backing for its autoimmune disease NETs

Citryll snares €15m backing for its autoimmune disease NETs Other companies including Bristol-Myers Squibb (via its $600m acquisition of Padlock Therapeutics in 2016) are working on small-molecule PAD inhibitors for autoimmune disease.

[ Previous 5 results ] 5 6 7 8 9 10 11 12 13 14 [ Next 5 results ]

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Oncosec

OncoSec is a clinical-stage biotechnology company focused on developing cytokine-based intratumoral immunotherapies to stimulate the body's immune system to target...

Latest intelligence

Five key trends in precision and personalised healthcare
Here, we deep dive into five of the key trends in precision medicine and personalised healthcare to explore how the healthcare industry is changing and how pharmaceutical and biotech companies...
OPEN Health Graduate Programme: from OPEN VIE to OPEN Health Medical Communications
Isobel Owens shares her experience of the OPEN Health Graduate Programme from OPEN VIE to OPEN Health Medical Communications...
Language barriers: Obesity has become a loaded word
...

Infographics